VOLITIONRX LTDVNRX決算レポート
NYSE
主要株主
| 株主 | 保有比率 | 株数 | 変動 | 基準日 |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 9.2M | — | 2024-11-14 |
| Nos. of Above Persons | 6.60% | 6.1M | ▲ +1.90pp | 2024-11-14 |
| Cameron Reynolds | 3.50% | 2.9M | — | 2024-02-09 |
インサイダー取引
Net 90d: +$0 · buys $0 / sells $0期間:
種別:
役職:
| インサイダー | 役職 | 種別 | ||||
|---|---|---|---|---|---|---|
| 2026-02-26-05:00 | Ethel Rubin | Director | Grant | 178.0K | $0.00 | $0 |
| 2026-02-26-05:00 | Gael Forterre | Chief Commercial Officer | Grant | 149.0K | $0.00 | $0 |
| 2026-02-26-05:00 | Batchelor Ann-Louise | Group Chief Marketing Officer | Grant | 142.0K | $0.00 | $0 |
| 2026-02-26-05:00 | Terig Hughes | Chief Financial Officer | Grant | 202.0K | $0.00 | $0 |
| 2026-02-26-05:00 | Nicholas Plummer | GC - Volition Diagnostics | Grant | 187.0K | $0.00 | $0 |
| 2026-02-26-05:00 | Rootsaert Rodney Gerard | Secretary | Grant | 119.0K | $0.00 | $0 |
| 2026-02-26-05:00 | Reynolds Cameron John | President and CEO | Grant | 486.0K | $0.00 | $0 |
| 2026-02-26-05:00 | Jasmine Kway | CEO - Singapore Volition | Grant | 173.0K | $0.00 | $0 |
| 2026-02-26-05:00 | Kim Nguyen | Director | Grant | 178.0K | $0.00 | $0 |
| 2026-02-26-05:00 | Micallef Jacob Vincent | Chief Scientific Officer | Grant | 149.0K | $0.00 | $0 |
1–10 of 11
1 / 2 ページ